Marksans Pharma Ltd. Share Price

Marksans Pharma Ltd. (INR)206.69-26.5 (-11.3%)

Exchange ScripsBSE524404NSEMARKSANSISININE750C01026

Stock Performance

Fundamentals

Technicals

Shareholding Patterns

Financials

Similar Stocks

Trendline of performance -

Marksans Pharma Ltd. Performance

Market performance

Open price233

High233.5

Volumes4129429

Prev Close206.69

Low202.1

Closing date2025-04-04

Historical performance

1 Year High358.70

3 Year High358.70

5 Year High358.70

1 Year Low130.00

3 Year Low38.60

5 Year Low16.05

Marksans Pharma Ltd. Fundamentals

Company Valuation

Market Cap (₹Cr)

10548

Face Value (₹)

P/E Ratio

29.86

Dividend Yield

0.29 %

Marksans Pharma Ltd. Investment Returns

1 Year

28.1%

3 Years

286%

5 Years

1296.6%

10 Years

209%

Marksans Pharma Ltd. Technicals

Indicators	Value	Signal
5-DMA	221.9	Bearish
10-DMA	222.41	Bearish
20-DMA	212.64	Bearish
50-DMA	227.28	Bearish
100-DMA	265.12	Bearish
200-DMA	251.75	Bearish

Shareholding Pattern

Field	Dec-2024	Sep-2024	Jun-2024	Mar-2024	Dec-2023
Promoters	2	2	2	2	2
Foreign Investors	---	---	---	---	---
Domestic Investors	2	2	2	2	2
Public Investors	259811	248843	235498	254697	237375
Government	---	---	---	---	---

Marksans Pharma Ltd. Financials

Below figures are in Rs. Crores

Particulars	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Other Income	504	593	419	67
Operating Profit	5090	3986	3007	3463
Interest	112	91	84	80
Depreciation	743	519	448	362
Profit Before Tax	4235	3377	2475	3022
Consolidated Net Profit	3137	2663	1846	2359
Adjusted EPS	7	6	5	6

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	453	453	409	409
Total Reserves	20197	16998	10682	8456
Minority Interest	209	199	207	189
Total Non-Current Liabilities	2052	843	571	237
Total Liabilities	26810	21904	16601	12280
Capital Work in Progress	54	72	7	56
Total Assets	26810	21904	16601	12280

Cash Flow

Below figures are in Rs. Crores

Particulars	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Cash Flow from Operating Activities	2304	2374	993	1786
Cash Flow from Investing Activities	-1408	-2592	-844	-448
Cash Flow from Financing Activitie	-687	1978	795	-153
Net Cash Inflow / Outflow	208	1760	944	1185

26%

Negative

Neutral

Positive

The stock has a PE ratio of 29.86.
3Y Stock Price CAGR of the stock is 55.0.
The stock has a beta of 1.2.
In the last financial year, the company had an EBITDA of ₹5090 Million.
The company generated revenue of ₹21774 Million in the previous financial year.

Marksans Pharma Ltd.

206.69-26.5 (-11.3%)

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1283788.8

No. of Shares: 6211.2

Performance:28.4%

P/L: ₹283788.8

Top Gainers

Symbol	Change%
BALPHARMA	122.23(13%)
VIPCLOTHNG	34.54(11%)
KSCL	1460.55(10%)
TECILCHEM	25.36(10%)
ACEINTEG	25.24(9%)

Top Losers

Symbol	Change%
GOLDIAM	307.45(-17%)
GRWRHITECH	2686.4(-16%)
PGIL	1059.2(-16%)
VIMTALABS	924.45(-15%)
ASALCBR	1196.9(-14%)
AARTIPHARM	695.85(-14%)
CAMLINFINE	150.55(-12%)
POKARNA	837.45(-12%)